Gut Lactic Acid Bacteria Research Articles

Antibacterial and antibiofilm activity of human gut lactic acid bacteria.

The present study focused on the antibacterial and antibiofilm activity of novel lactic acid bacterial (LAB) strains isolated from the healthy human volunteers of different age groups and their consortium (LABCON), against the enteropathogenic bacteria. From the study, methanolic extract of LAB isolates and their consortia were found to have promising antibacterial activity and antibiofilm activity against Escherichia coli (ATCC 35218) and Staphylococcus aureus (ATCC 25923). The antimicrobial compounds including the DL-3 phenyllactic acid, DL-p-hydroxyphenyllactic acid, and Succinic acid produced by the LAB could be considered to inhibit the growth and biofilm formation by E. coli (ATCC 35218) and S. aureus (ATCC 25923). Detailed insight into the antibiofilm activity could also be demonstrated by Confocal Raman microscopy attached with AFM and Fluorescent microscope. From the results of the study, the consortium LABCON was superior in antimicrobial and antibiofilm activity and can be considered to have promising application in infection control.

Interactive Effects of Dietary Probiotic and Succinic Acid on the Growth Performance, Digestive Enzyme Activities, Immunomodulation, Antioxidative Capacity, and Disease Resistance in Rainbow Trout (Oncorhynchus mykiss) Juveniles

Abstract The current study was carried out to explore the effects of lactofeed (LA) as a multi-strain probiotic and succinic acid (SA) on growth variables, gut lactic acid bacteria count, digestive enzymes, innate immune responses, antioxidant capacity, and resistance against yersinia ruckeri in rainbow trout juveniles (Oncorhynchus mykiss). Three hundred sixty healthy rainbow trout juveniles (13.21±0.41 g) were randomly divided into twelve tanks (300 L) as four experimental groups. They were fed with basal diet (Control; BD), FT1: BD + 1 g/kg LA, FT2: BD + 5 g/kg SA, and FT3: BD + 1 g/kg LA + 5 g/kg SA for eight weeks. According to the results, final weight (FW), weight gain (WG), protein efficiency rate (PER), and feed conversion rate (FCR) revealed a remarkable discrepancy compared to the control group. In addition, dietary inclusion of LA (FT1 and FT3) significantly increased the specific growth rate (SGR). Dietary supplementation of LA+SA (FT3) remarkably improved total bacteria count (TBC) and amylase activity compared to the unsupplemented group. Gut lactic acid bacteria (LAB) count and digestive protease activity in all supplemented fish were remarkably higher than in unsupplemented group. Blood immunological factors including white blood cell (WBC) count, total immunoglobulin content (Ig), and the activity of lysozyme (LYZ), alternative complement pathway (ACH50), and acid phosphatase (ACP) were significantly enhanced in the supplemented groups. Neutrophil (NEU) count, skin mucus Ig and hepatic glutathione peroxidase (GPX) increased in SA (FT2 and FT3) treatments. In addition, monocyte (MON) count and skin mucus LYZ activity were significantly elevated following feeding with the FT3 diet. Other immunological parameters of skin mucus including protease activity, alkaline phosphatase (ALP) activity, and ACH50 activity, as well as hepatic superoxide dismutase (SOD) and catalase (CAT) activities increased in fish fed with diets containing LA and/or SA. Malondialdehyde (MDA) value was remarkably decreased in all supplemented rainbow trout compared to the fish fed with BD. Disease resistance against Y. ruckeri in fish fed with supplemented diets significantly improved with respect to the results obtained in the control specimens. Overall, dietary LA+SA supplementation was beneficial to improve growth performance, gut LAB count, digestive enzyme activities, innate immune responses, antioxidant capacity, and disease resistance in rainbow trout. According to these findings, 1 g/kg LA + 5 g/kg SA is suggested for adding to rainbow trout diet.

Fermented sunflower meal in diets for Atlantic salmon under commercial-like farming conditions promotes gut lactic acid bacteria and controls inflammation in the distal intestine

The global increase of aquaculture production has caused an escalating demand for alternative protein feed ingredients. Agro-industrial by-products such as sunflower meal are relatively abundant and cheap, but the content of antinutritional factors and fiber in the raw products reduce nutritional value and limit the inclusion levels in the feed for nutritionally demanding species, including salmonids. Solid-state fermentation is a microbial processing method with the potential to reduce the content of fiber and antinutritional factors and improve nutritional value in plant protein raw materials. In this study, Atlantic salmon (Salmo salar) at two commercial-like fish farms were fed experimental diets containing either 5 % non-fermented sunflower meal (as a control diet), 5 % fermented sunflower meal or 10 % fermented sunflower meal. The aim was to compare the effects of fermented sunflower meal on growth performance, gut microbiota, distal intestine histology and gene expression of Atlantic salmon under different environmental conditions. The field trial lasted for 8 and 11 months in a coastal and fjord location, respectively. The findings revealed that diets with fermented sunflower meal sustained growth performance, improved intestinal health by reducing the prevalence of prominent inflammation and ectopic goblet cells, as well as down-regulated the expression of physiological pathways related to tissue damage and cell division. Additionally, 10 % fermented sunflower meal promoted the relative abundance of gut lactic acid bacteria Lactiplantibacillus and Lactobacillaceae after long-term feeding. Our results suggest that fermented sunflower meal is a suitable protein source for Atlantic salmon when included at a level of up to 10 % in the diet.

Dietary Tartaric Acid Improves Growth Performance, Gut Microbiota, Digestive Enzyme Activities, Hemolymph Immunity, Antioxidant Markers, and Disease Resistance against Vibrio parahaemolyticus in Pacific White Shrimp

Tartaric acid (TA) is an organic acid whose properties in aquaculture have not yet been comprehensively studied. In the current research, the effect of dietary TA on growth indices, gut microbiota, the level of digestive enzymes, antioxidant and immunological markers, and survival rate following immersion challenge with Vibrio parahaemolyticus (14 days) in Litopenaeus vannamei were investigated. To achieve this, 600 shrimp (3.26 ± 0.05 g) were tested with pellets supplemented with five distinct concentrations of TA including 0 (TA0), 2.5 (TA2.5), 5 (TA5), 7.5 (TA7.5), and 10 g/kg (TA10) for 56 days. The results showed that the growth performance, feed utilization, gut lactic acid bacteria (LAB) count, and activity of digestive enzymes were markedly elevated in the groups receiving diets incorporated with 5 and 7.5 g/kg of TA. The highest total hemocyte count (THC), hyaline cell (HC), and semi-granular cell (SGC) counts were detected in shrimp fed with the TA7.5 diet. Hemolymph immune responses including LYZ (lysozyme), alkaline phosphatase (AKP), acid phosphatase (ACP), and phenol oxidase (PO) activities were significantly enhanced in all TA-treated groups. Dietary TA7.5 significantly boosted all antioxidant enzymes. In addition, malondialdehyde (MDA) content illustrated a significant decrease in shrimp fed with diets supplemented with 2.5–10 g/kg TA when compared with specimens fed with TA0. The survival rate following the immersion challenge with Vibrio parahaemolyticus markedly increased in all shrimp treated with 2.5–10 g/kg TA compared to TA0, irrespective of the dosage. However, the dietary inclusion of TA7.5 resulted in the highest survival rate. Based on the outcomes, dietary TA, especially at the concentration of 7.5 g/kg, is proposed to promote the growth performance and immunological indicators of L. vannamei.

Understanding Age-Related Longitudinal Dynamics in Abundance and Diversity of Dominant Culturable Gut Lactic Acid Bacteria in Pastured Goats.

Understanding gut lactic acid bacteria (LAB) in healthy hosts is an important first step in selecting potential probiotic species. To understand the dynamics of LAB in healthy goats, a cohort of thirty-seven healthy new-born goat kids was studied over a ten-month period. Total LAB was quantified using SYBR green qPCR. Seven hundred LAB isolates were characterized using microscopy, M13 RAPD genotyping and 16S rDNA sequencing. The highest and lowest LAB counts were detected at one week and ten months of age, respectively. Diverse LAB species were detected, whose identity and prevalence varied with age. The main isolates belonged to Limosilactobacillus reuteri, Limosilactibacillus fermentum, Lactobacillus johnsonni, Ligilactobacillus murinus, Ligilactobacillus salivarius, Limosilactobacillus mucosae, Lactiplantibacillus plantarum, Ligilactobacillus agilis, Lactobacillus acidophilus/amyolovolus, Pediococcus spp. and Enterococcus spp. Uniquely, L. reuteri and Pediococcus spp. were most common in pre- and peri-weaned goats, while Lactobacillus mucosae and Enterococcus spp. were predominant in goats one month and older. Based on RAPD genotyping, L. reuteri had the highest genotypic diversity, with age being a factor on the genotypes detected. This data may be relevant in the selection of age-specific probiotics for goats. The findings may also have broader implications by highlighting age as a factor for consideration in probiotic bacteria selection in other animal hosts.

Lactic acid bacteria–derived γ-linolenic acid metabolites are PPARδ ligands that reduce lipid accumulation in human intestinal organoids

Gut microbiota regulate physiological functions in various hosts, such as energy metabolism and immunity. Lactic acid bacteria, including Lactobacillus plantarum, have a specific polyunsaturated fatty acid saturation metabolism that generates multiple fatty acid species, such as hydroxy fatty acids, oxo fatty acids, conjugated fatty acids, and trans-fatty acids. How these bacterial metabolites impact host physiology is not fully understood. Here, we investigated the ligand activity of lactic acid bacteria-produced fatty acids in relation to nuclear hormone receptors expressed in the small intestine. Our reporter assays revealed two bacterial metabolites of γ-linolenic acid (GLA), 13-hydroxy-cis-6,cis-9-octadecadienoic acid (γHYD), and 13-oxo-cis-6,cis-9-octadecadienoic acid (γKetoD) activated peroxisome proliferator-activated receptor delta (PPARδ) more potently than GLA. We demonstrate that both γHYD and γKetoD bound directly to the ligand-binding domain of human PPARδ. A docking simulation indicated that four polar residues (T289, H323, H449, and Y473) of PPARδ donate hydrogen bonds to these fatty acids. Interestingly, T289 does not donate a hydrogen bond to GLA, suggesting that bacterial modification of GLA introducing hydroxy and oxo group determines ligand selectivity. In human intestinal organoids, we determined γHYD and γKetoD increased the expression of PPARδ target genes, enhanced fatty acid β-oxidation, and reduced intracellular triglyceride accumulation. These findings suggest that γHYD and γKetoD, which gut lactic acid bacteria could generate, are naturally occurring PPARδ ligands in the intestinal tract and may improve lipid metabolism in the human intestine.

Antimicrobial compound produced by human gut lactic acid bacteria having antifungal activity against aflatoxigenic Aspergillus flavus MTCC 2798

Lactic acid bacteria (LAB) are a group of distinguished bacteria that have reserved their place in the food industry, with their probiotic properties as well as their ability to produce many antimicrobial compounds. The antagonistic microorganisms and their bioactive compounds have a potential application as natural bio preservatives as they not only inactivate but also inhibit the growth of undesired microorganisms in food. Hence, the use of LAB and their antimicrobial compounds like organic acids, hydrogen peroxide, diacetyl, bacteriocins, etc. attract considerable interest during the past years. Among the 173 human gut LAB studied 17 isolates showed antifungal activity against aflatoxigenic Aspergillus flavus MTCC 2798. All the seventeen isolates produced antimicrobial compounds such as lactic acid, hydrogen peroxide, diacetyl. GC–MS based metabolic profiling of the methanolic extracts of 17 isolates identified 40 metabolites. Thirteen metabolites were identified and reported to have potent antimicrobial activity. The results suggest the antagonistic potential of antimicrobial compounds produced by human gut LAB having significant application in the pharmaceutical and food industry. Novelty impact statement Antimocrobial compounds were produced by seventeen antifungal human gut Lactic acid bacteria have promising application as food preservative. GC–MS based metabolic profiling of the methanolic extracts of 17 isolates identified thirteen metabolites reported to have potent antimicrobial activity. Bioactive metabolite Cyclo(leucyl prolyl), was present in the methonolic extract of all the seventeen LAB isolates reported to have anti-aflatoxin activity, thus confirms the anti-aflatoxigenic property of the isolates.

Probiotic Potential and Effects on Gut Microbiota Composition and Immunity of Indigenous Gut Lactobacilli in Apis cerana.

This study aimed to investigate the probiotic potential of gut indigenous lactic acid bacteria (LAB) originated from Apis cerana. Six Limosilactobacillus reuteri and one Lactobacillus helveticus were isolated from gut samples of A. cerana adult worker bee. All isolates antagonized the growth of pathogens including Salmonella typhimurium, Escherichia coli, Shigella flexneri, and Flavobacterium frigidimaris, and L. helveticus KM7 showed the greatest antimicrobial activity among them. All strains were sensitive to cefotaxime, amoxicillin, cephalothin, penicillin G, kanamycin, and vancomycin, moderately sensitive to novobiocin and resistant to gentamicin. Six out of seven strains were sensitive to ampicillin. L. helveticus KM7 was chosen to evaluate in vivo probiotic effect of adult worker bees of A. cerana through fed sucrose syrup supplemented with KM7. Administration of KM7 increased survival rate and gut LAB but decreased gut fungi and Enterococcus in honeybees. Expressions of genes related to antimicrobial peptides (AMPs) including Abaecin and Defensin were also induced in the gut of honeybees. The results suggested that L. helveticus KM7 with greater probiotic properties could improve the survival rate of adult worker honeybees of A. cerana through regulating gut microbiota and AMPs genes expression.

Growth Enhancing Effects of Squid By-Product Hydrolysate in Plant Protein-Based Diet Fed to Black Tiger Shrimp, Penaeus monodon Fabricius, 1798

The present study evaluated the potential of squid by-product hydrolysate as fishmeal replacement in the plant-based diet of juvenile black tiger shrimp, Penaeus monodon Fabricius, 1798. Five experimental plant protein-based diets were formulated containing squid by-product hydrolysate to replace fishmeal at 0, 25, 50, 75 and 100 %. These experimental diets were fed to triplicate groups of P. monodon for 8 weeks. Results revealed that 25 % fishmeal replacement with squid by-product hydrolysate resulted in growth enhancement, attributable to increased feed intake and gut lactic acid bacteria proliferation. The shrimp fed with 100 % replacement level exhibited a similar growth response with the control group. Protein retention was not affected by the fishmeal replacement levels, but lipid retention was found higher in all treatments with squid by-product hydrolysate than the control. Digestive protease activity decreased with increasing levels of hydrolysate while α-amylase and lipase activities were not affected. Hepatopancreas histology showed thatB-cells dominated the control group while R-cells proliferated with increasing inclusion of dietary squid by-product hydrolysate. These results collectively indicate that fishmeal could be totally replaced with squid by-product hydrolysate and 25 % fishmeal replacement could promote the growth of juvenile P. monodon.

Antifungal activity of human gut lactic acid bacteria against aflatoxigenic Aspergillus flavus MTCC 2798 and their potential application as food biopreservative

AbstractWith the enhanced use of chemical preservatives and the survival of foodborne pathogens, lactic acid bacteria and its metabolic product have received increased attention as a potential food preservative. Even though the antibacterial property of lactic acid bacteria is well known, its antifungal property and application in food preservation have not been widely exploited. Considering these facts, this study was conducted to investigate the antifungal properties of three human gut lactic acid bacterial isolates, Lactobacillus plantarum AL1, Lactobacillus fermentum AL2, and Weissella confusa AL3 antifungal activity of the isolates were studied against the aflatoxigenic Aspergillus flavus MTCC 2798, using the agar overlay method and inhibition of fungal mycelium (co‐culture method). These LAB isolates were also potent producers of antimicrobial compounds like lactic acid, hydrogen peroxide, and diacetyl. GC–MS analysis of the methanolic extract of the three LAB isolates detected two antifungal bioactive compounds like cyclo (leucyloprolyl) and 1,2‐benzenedicarboxylic acid in extracts. The hemolysis results provided an important insight that the human gut lactic acid bacteria can be used as protective cultures in the biopreservation. The antifungal activity of human gut LAB AL1, AL2, and AL3 against aflatoxigenic Aspergillus flavus MTCC 2798 and its ability extend the shelf life of peanuts prove as a natural preservative for food products.

The diversity and composition of the human gut lactic acid bacteria and bifidobacterial microbiota vary depending on age.

Aging is associated with gut microbiota alterations, characterized by changes in intestinal microbial diversity and composition. However, no study has yet focused on investigating age-related changes in the low-abundant but potentially beneficial subpopulations of gut lactic acid bacteria (LAB) and Bifidobacterium. Our study found that the subjects' age correlated negatively with the alpha diversity of the gut bifidobacterial microbiota, and such correlation was not observed in the gut LAB subpopulation. Principal coordinate analysis (PCoA) and analysis of distribution of operational taxonomic units (OTUs) revealed that the structure and composition of the gut bifidobacterial subpopulation of the longevous elderly group were rather different from that of the other three age groups. The same analyses were applied to identify age-dependent characteristics of the gut LAB subpopulation, and the results revealed that the gut LAB subpopulation of young adults was significantly different from that of all three elderly groups. Our study identified several potentially beneficial bacteria (e.g., Bifidobacterium breve and Bifidobacterium longum) that were enriched in the longevous elderly group (P < 0.05), and the relative abundance of Bifidobacterium adolescentis decreased significantly with the increase in age (P < 0.05). Although both bifidobacteria and LAB are generally considered as health-promoting taxa, their age-dependent distribution varied from each other, suggesting their different life stage changes and potentially different functional roles. This study provided novel species-level gut bifidobacterial and LAB microbiota profiles of a large cohort of subjects and identified several age-or longevity-associated features and biomarkers. KEY POINTS: • The alpha diversity of the gut bifidobacterial microbiota decreased with age, while LAB did not change. • The structure and composition of the gut bifidobacterial subpopulation of the longevous elderly group were rather different from that of the other three age groups. • Several potentially beneficial bacteria (e.g., Bifidobacterium breve and Bifidobacterium longum) that were enriched in the longevous elderly group.

Gut probiotic bacteria of Barbonymus gonionotus improve growth, hematological parameters and reproductive performances of the host

This study aimed to isolate and identify probiotic bacteria from the gut of Barbonymus gonionotus and evaluate their effects on growth, hematological parameters, and breeding performances of the host. Five probiotic bacteria viz. Enterococcus xiangfangensis (GFB-1), Pseudomonas stutzeri (GFB-2), Bacillus subtilis (GFB-3), Citrobacter freundii (GFB-4), and P. aeruginosa (GFB-5) were isolated and identified using 16S rRNA gene sequencing. Application of a consortium of probiotic strains (1–3 × 1.35 × 109 CFU kg−1) or individual strain such as GFB-1 (1.62 × 109 CFU kg−1), GFB-2 (1.43 × 109 CFU kg−1), GFB-3 (1.06 × 109 CFU kg−1), GFB-4 (1.5 × 109 CFU kg−1) or GFB-5 (1.43 × 109 CFU kg−1feed) through feed significantly improved growth, histological and hematological parameters and reproductive performances of B. gonionotus compared to untreated control. Moreover, the application of these probiotics significantly increased gut lactic acid bacteria and activities of digestive enzymes but did not show any antibiotic resistance nor any cytotoxicity in vitro. The highest beneficial effects on treated fishes were recorded by the application of GFB-1, GFB-2, GFB-3, and a consortium of these bacteria (T2). This is the first report of the improvement of growth and health of B. gonionotus fishes by its gut bacteria.

Microbial community analysis of viable cells and genomes in kyejang, a traditional Korean fermented beverage

The relationship between diet and gut microbial community is widely studied, and foods that might be sources of beneficial microorganisms have garnered interest. Here, we analyzed the changes in the microbial community of kyejang, a traditional Korean fermented beverage, made with nuruk, cinnamon, and medicinal herbs fermented at 10, 20, and 30 °C for 7 days. Using selective media, the decrease in the numbers of Bacillus pumilus, B. amyloliquefaciens, and B. subtilis colony-forming units was observed from the initial fermentation stage to day 7, whereas those of Leuconostoc mesenteroides and Lactobacillus curvatus increased during this period. Next-generation sequencing revealed 719 operational taxonomic units (OTUs) at the onset of fermentation of kyejang (control), confirming the presence of diverse microorganisms. Leuconostoc spp. was dominant for 7 days at 10 °C and 20 °C, whereas Lactobacillus spp. was dominant for 7 days at 30 °C. Therefore, the microbial community of fermented kyejang was dominated by lactic acid bacteria; however, the number of OTUs decreased to 43 within 7 days of fermentation at 30 °C, indicating that the microbial community simplified as fermentation proceeded. Based on these results, kyejang is expected to contribute to the diversity of gut lactic acid bacteria and traditional beverages.

Elucidation of Gut Microbiota-Associated Lipids Using LC-MS/MS and 16S rRNA Sequence Analyses.

SummaryHost-microbiota interactions create a unique metabolic milieu that modulates intestinal environments. Integration of 16S ribosomal RNA (rRNA) sequences and mass spectrometry (MS)-based lipidomics has a great potential to reveal the relationship between bacterial composition and the complex metabolic network in the gut. In this study, we conducted untargeted lipidomics followed by a feature-based molecular MS/MS spectral networking to characterize gut bacteria-dependent lipid subclasses in mice. An estimated 24.8% of lipid molecules in feces were microbiota-dependent, as judged by > 10-fold decrease in antibiotic-treated mice. Among these, there was a series of unique and microbiota-related lipid structures, including acyl alpha-hydroxyl fatty acid (AAHFA) that was newly identified in this study. Based on the integrated analysis of 985 lipid profiles and 16S rRNA sequence data providing 2,494 operational taxonomic units, we could successfully predict the bacterial species responsible for the biosynthesis of these unique lipids, including AAHFA.

Effect of diets with different levels of soybean meal and Kemin multi-enzyme on growth performance, body composition, and gut lactic acid bacteria of juvenile Beluga (Huso huso)

Effect of diets with different levels of soybean meal and Kemin multi-enzyme on growth performance, body composition, and gut lactic acid bacteria of juvenile Beluga (Huso huso)

Novel Mechanism of Fatty Acid Sensing in Enteroendocrine Cells: Specific Structures in Oxo-Fatty Acids Produced by Gut Bacteria Are Responsible for CCK Secretion in STC-1 Cells via GPR40.

The secretion of gut hormones, such as cholecystokinin (CCK) is stimulated by fatty acids. Although a chain length-dependent mechanism has been proposed, other structural relationships to releasing activity remain unclear. We aimed to elucidate specific structures in fatty acids that are responsible for their CCK-releasing activity, and related sensing mechanisms in enteroendocrine cells. CCK secretory activities were examined in a murine CCK-producing cell line STC-1 by exposing the cells to various modified fatty acids produced by gut lactic acid bacteria. The effects of fatty acids on gastric emptying rate as a CCK-mediated function were examined using acetaminophen and phenol red methods in rats. Out of more than 30 octadecanoic-derived fatty acids tested, 5 oxo-fatty acids potently stimulated CCK secretion without cytotoxic effects in STC-1 cells. Three fatty acids had a distinct specific structure containing one double bond, whereas the other two had two double bonds, nearby an oxo residue. CCK secretion induced by representative fatty acids (10-oxo-trans-11-18:1 and 13-oxo-cis-9,cis-15-18:2) was attenuated by a fatty acid receptor G-protein coupled receptor 40 antagonist. Oral administration of 13-oxo-cis-9,cis-15-18:2 lowered the gastric emptying rate in rats in a dose- and structure-dependent manner. These results reveal a novel fatty acid-sensing mechanism in enteroendocrine cells.

Effect of canola meal inclusion as a major protein source in gestation and lactation sow diets with or without enzymes on reproductive performance, milk composition, fecal bacterial profile and nutrient digestibility

The aim was to determine the effects of high canola meal (CM) inclusion in gestation and lactation diets on reproductive performance, milk composition, fecal bacterial profile and nutrient and energy digestibility of sows. Forty-five sows were randomly assigned to 1 of 3 dietary treatments consisting of a corn-soybean meal control diet, control diet containing 300 g/kg solvent-extracted CM with or without multi-enzyme complex (MC). Sows were individually housed and offered the experimental diets from day 60 of gestation until weaning on day 21. Sows were weighed and backfat thickness measured on days 60 and 111 of gestation, and on days 0 and 21 post-farrowing. Litters were weighed on days 0 and 21. Weaning to estrus interval in sows was recorded. Blood and milk samples were collected 2 h post-feeding from sows on days 0 and 21 to determine the plasma urea nitrogen (PUN) content and milk composition. Fecal samples were collected from sows during lactation to determine energy and nutrient digestibility, and during gestation and lactation to determine the fecal bacterial profile. There were no dietary effects on lactation feed intake, sow backfat loss, weaning to estrus interval and milk fat, protein and lactose composition, and suckling piglet performance except for sow body weight (BW) loss during lactation, wherein sows fed CM-containing diets with MC had lower (P < 0.05) BW loss than those fed the control diet. Sows fed diets containing CM (with and without MC) had lower (P < 0.05) PUN values compared with those fed the control diet on day 21 post-farrowing. Apparent total tract digestibility (ATTD) of energy and nutrients showed no dietary effect except for ATTD of phosphorus (P), wherein sows fed CM-containing diets with MC showed higher (P < 0.05) P digestibility compared to those fed CM-containing diets without MC. Sows fed CM-containing diets with or without MC had greater (P < 0.05) abundances of Lactobacillus and Enterococcus and lower (P < 0.05) abundances of Firmicutes when compared to those fed the control diet on day 90 of gestation. In conclusion, inclusion of up to 300 g/kg CM in gestation and lactation diet can support satisfactory sow and suckling piglet performance without affecting energy and nutrient digestibility, along with an increase in the abundance of gut lactic acid bacteria in sows. Moreover, enzyme supplementation reduced the sow BW loss and improved P digestibility in CM diets.

Immune response and disease resistance in the white shrimp, Litopenaeus vannamei induced by potential probiotic Lactobacillus bulgaricus

In the present study, Lactobacillus bulgaricus E20 isolated from the gut contents of farm-reared white shrimp, Litopenaeus vannamei, after determination of its characteristics using biochemical, molecular and probiotical examinations, was used in the diet of white shrimp to evaluate the survival rate, immune status, and disease resistance. L. bulgaricus was administered at two different doses 1×107 (T1) and 1×109 (T2) CFU g_1 feed to shrimp for 30 days. A control group was also included with normal feed. The survival rate, total hemocyte counts, phenoloxidase activity, respiratory burst, gut lactic acid bacteria and gut total bacteria were evaluated at the end of trial and after challenging shrimp with Vibrio parahaemolyticus. Higher survival rates were observed in shrimp fed probiotic diets as compared with the control (P<0.05). The best immune performance in terms of hemocyte counts, phenoloxidase activity, and respiratory burst was seen in the probiotic-treated groups especially in T2. Also, an improvement was seen in the number of lactic acid bacterias in shrimp that had been given probiotics. There were no significant differences between groups (treated and control) after exposing with V. parahemolyticus (P<0.05). Shrimp fed with probiotic diets revealed lower cumulate mortality than the control group. These findings demonstrated that administration of L. bulgaricus can improve survival rate and disease resistance through an enhanced immune response in shrimp

α-Linolenic acid-derived metabolites from gut lactic acid bacteria induce differentiation of anti-inflammatory M2 macrophages through G protein-coupled receptor 40.

Among dietary fatty acids with immunologic effects, ω-3 polyunsaturated fatty acids, such as α-linolenic acid (ALA), have been considered as factors that contribute to the differentiation of M2-type macrophages (M2 macrophages). In this study, we examined the effect of ALA and its gut lactic acid bacteria metabolites 13-hydroxy-9(Z),15(Z)-octadecadienoic acid (13-OH) and 13-oxo-9(Z),15(Z)-octadecadienoic acid (13-oxo) on the differentiation of M2 macrophages from bone marrow-derived cells (BMDCs) and investigated the underlying mechanisms. BMDCs were stimulated with ALA, 13-OH, or 13-oxo in the presence of IL-4 or IL-13 for 24 h, and significant increases in M2 macrophage markers CD206 and Arginase-1 (Arg1) were observed. In addition, M2 macrophage phenotypes were less prevalent following cotreatment with GPCR40 antagonists or inhibitors of PLC-β and MEK under these conditions, suggesting that GPCR40 signaling is involved in the regulation of M2 macrophage differentiation. In further experiments, remarkable M2 macrophage accumulation was observed in the lamina propria of the small intestine of C57BL/6 mice after intragastric treatments with ALA, 13-OH, or 13-oxo at 1 g/kg of body weight per day for 3 d. These findings suggest a novel mechanism of M2 macrophage differentiation involving fatty acids from gut lactic acid bacteria and GPCR40 signaling.-Ohue-Kitano, R., Yasuoka, Y., Goto, T., Kitamura, N., Park, S.-B., Kishino, S., Kimura, I., Kasubuchi, M., Takahashi, H., Li, Y., Yeh, Y.-S., Jheng, H.-F., Iwase, M., Tanaka, M., Masuda, S., Inoue, T., Yamakage, H., Kusakabe, T., Tani, F., Shimatsu, A., Takahashi, N., Ogawa, J., Satoh-Asahara, N., Kawada, T. α-Linolenic acid-derived metabolites from gut lactic acid bacteria induce differentiation of anti-inflammatory M2 macrophages through G protein-coupled receptor 40.

10-oxo-12(Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, enhances energy metabolism by activation of TRPV1.

Gut microbiota can regulate the host energy metabolism; however, the underlying mechanisms that could involve gut microbiota-derived compounds remain to be understood. Therefore, in this study, we investigated the effects of KetoA [10-oxo-12(Z)-octadecenoic acid]-a linoleic acid metabolite produced by gut lactic acid bacteria-on whole-body energy metabolism and found that dietary intake of KetoA could enhance energy expenditure in mice, thereby protecting mice from diet-induced obesity. By using Ca2+ imaging and whole-cell patch-clamp methods, KetoA was noted to potently activate transient receptor potential vanilloid 1 (TRPV1) and enhance noradrenalin turnover in adipose tissues. In addition, KetoA up-regulated genes that are related to brown adipocyte functions, including uncoupling protein 1 (UCP1) in white adipose tissue (WAT), which was later diminished in the presence of a β-adrenoreceptor blocker. By using obese and diabetic model KK-Ay mice, we further show that KetoA intake ameliorated obesity-associated metabolic disorders. In the absence of any observed KetoA-induced antiobesity effect or UCP1 up-regulation in TRPV1-deficient mice, we prove that the antiobesity effect of KetoA was caused by TRPV1 activation-mediated browning in WAT. KetoA produced in the gut could therefore be involved in the regulation of host energy metabolism.-Kim, M., Furuzono, T., Yamakuni, K., Li, Y., Kim, Y.-I., Takahashi, H., Ohue-Kitano, R., Jheng, H.-F., Takahashi, N., Kano, Y., Yu, R., Kishino, S., Ogawa, J., Uchida, K., Yamazaki, J., Tominaga, M., Kawada, T., Goto, T. 10-oxo-12(Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, enhances energy metabolism by activation of TRPV1.